Cellular immune responses to ESAT-6 discriminate between patients with pulmonary disease due to Mycobacterium avium complex and those with pulmonary disease due to Mycobacterium tuberculosis
Ad. Lein et al., Cellular immune responses to ESAT-6 discriminate between patients with pulmonary disease due to Mycobacterium avium complex and those with pulmonary disease due to Mycobacterium tuberculosis, CL DIAG LAB, 6(4), 1999, pp. 606-609
ESAT-6 (for 6-kDa early secreted antigenic target) is a secreted antigen fo
und almost exclusively in organisms of the Mycobacterium tuberculosis compl
ex. We compared in vitro gamma interferon (IFN-gamma) responses by peripher
al blood mononuclear cells to this antigen in patients with pulmonary disea
se due to either Mycobacterium avium complex (MAC) or Mycobacterium tubercu
losis with those in healthy, skin test-negative, control subjects. Signific
ant IFN-gamma responses to ESAT-6 were detected in 16 (59%) of 27 M, tuberc
ulosis pulmonary disease patients, 0 (0%) of 8 MAC disease patients, and 0
(0%) of 8 controls. Significant IFN-gamma responses to M, tuberculosis puri
fied protein derivative were detected in 23 (85%) of 27 M, tuberculosis dis
ease patients, 2 (25%) of 8 MAC disease patients, and 5 (63%) of 8 healthy
controls. M, avium sensitin was recognized in 24 (89%) of 27 M, tuberculosi
s disease patients, 4 (50%) of 8 MAC disease patients, and 1 (13%) of 8 con
trols. IFN-gamma responses to ESAT-6 are specific for disease due to M, tub
erculosis and are not observed in patients with MAC disease or in healthy c
ontrols.